Levitee Labs Announces Gold Sponsorship of Wonderland Psychedelic Conference in Miami
Levitee Labs, participating as a Gold Sponsor at the Wonderland Miami Conference, emphasizes its role in the psychedelic medicine industry. Scheduled for November 8-9, 2021, at the Adrienne Arsht Center, this event will gather influential figures from business and science, including notable speakers like Mike Tyson and Lamar Odom. Levitee Labs aims to lead in integrative wellness, operating clinics and pharmacies focused on addiction treatment and mental health. The company’s strategic positioning at such a significant conference may enhance its visibility and networking opportunities in a rapidly evolving sector.
- Levitee Labs is a Gold Sponsor and VIP Lounge Sponsor at the prominent Wonderland Miami Conference, enhancing its industry presence.
- The participation provides networking opportunities with leaders in the psychedelic medicine field, potentially leading to future collaborations.
- None.
- Levitee Labs will be a Gold Sponsor and VIP Lounge Sponsor at the world’s largest psychedelic medicine conference
- If you would like to attend either of Levitee’s private events, you can register at this link and Levitee Labs’ team will share more details: https://leviteelabs.com/contact/
VANCOUVER, British Columbia, Nov. 05, 2021 (GLOBE NEWSWIRE) -- Levitee Labs Inc. (the "Company" or "Levitee Labs”) (CSE: LVT), (OTC: LVTTF), (FSE: 7H7) an integrative wellness company with a diversified portfolio of healthcare and wellness assets, is pleased to announce its participation as a Gold Sponsor at the Wonderland Miami Conference organized by Microdose. This will be the largest in-person conference in the psychedelic medicine industry. The conference will take place on November 8th and 9th at the Adrienne Arsht Center for Performing Arts in Miami. The conference will offer a unique in-person convergence of business, science, music, and emerging technologies.
Wonderland Miami by Microdose is also a thought-leadership platform and an opportunity to connect with influential leaders in science, policy, and business. Microdose has announced an impressive line-up of speakers, including Drs. Matthew Johnson, Robin Carhart-Harris, and Rick Doblin. Other featured speakers at the event include Mike Tyson, former professional boxer and undisputed heavyweight champion, who has advocated for the use of psychedelic drugs, as well as Lamar Odom, a two-time NBA Champion and Olympic Gold Medalist.
Levitee Labs will also be the VIP Lounge Sponsor and an After Dark Sponsor for the conference.
About Levitee Labs Inc.
Levitee is establishing itself as a leader in the integrative wellness space. Through leveraging an M&A regimen that focuses on the centralization of complementary integrative wellness assets, Levitee aims to transform mental health and addiction treatments through the integration of psychedelic medicines and therapies. The Company’s current portfolio of assets includes: Levitee Clinics™, a group of five operating addiction and pain treatment clinics in Alberta; Levitee Pharmacies™, three pharmacies operating in Alberta specializing in filling prescriptions for patients with substance use disorders, mental health conditions, and chronic pain; BlockMD, the first technology company in Alberta to receive provincial approval for electronic-prescriptions in the addiction treatment space; and Earth Circle Organics, a direct-to-consumer and wholesaler of supplements and superfood products with 180+ SKUs in its product lineup across three brands. Further information about Levitee is available on its website at www.leviteelabs.com.
Forward-Looking Statements
This news release contains certain statements that may constitute forward-looking information under applicable securities laws. All statements, other than those of historical fact, which address activities, events, outcomes, results, developments, performance, or achievements that Levitee anticipates or expects may or will occur in the future (in whole or in part) should be considered forward-looking information. Such information may involve, but is not limited to, statements respecting Levitee’s business plans and proposed products, and the benefits derived from mushroom-infused products; the expected use of proceeds from the Loan; the acquisitive growth potential of Levitee once acquisitions are completed; the expectation that Levitee will continue to execute its accretive acquisition program, and the contribution of such program to Levitee’s future growth potential; the closing of Tranche 1, including the Levitee’s ability to satisfy the Tranche 1 closing conditions; the closing of any future tranches under the Loan, including Levitee’s ability to satisfy the closing conditions for future tranches of the Loan; and Levitee’s objective to transform mental health and addiction treatments through the integration of psychedelic medicines and therapies. Often, but not always, forward-looking information can be identified by the use of words such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates”, or “believes” or variations (including negative variations) of such words and phrases, or statements formed in the future tense or indicating that certain actions, events or results “may”, “could”, “would”, “might” or “will” (or other variations of the forgoing) be taken, occur, be achieved, or come to pass. These statements and other forward-looking information are based on assumptions made by Levitee based on currently available competitive, financial and economic data and operating plans, strategies or beliefs as of the date of this news release as well as management’s current expectations or beliefs regarding future growth, results of operations, future capital (including the amount, nature and sources of funding thereof) and expenditures. These assumptions may also be based on information obtained from third-party industry analysts and other third-party sources. Forward-looking information is necessarily based on a number of opinions, assumptions and estimates that, while considered reasonable by Levitee as of the date such statements are made, are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, performance or achievements to be materially different from those expressed or implied by such forward-looking information, including but not limited to risks associated with the following: Levitee’s limited history of operations; ability to secure additional financing; negative cash flow from operating activities since inception; regulatory requirements; changes in consumer preferences; supply of raw materials; reliance on a limited number of products; brand awareness; the ability to develop, market and produce new products; dependence on certain key senior managers; reliance on third parties for manufacturing and packaging; potential product liability claims and product recalls; and significant competition. For additional information regarding these risks, please see the risk factors identified and reported in Levitee’s public filings under its SEDAR profile at www.sedar.com. Any and all forward-looking information contained in this press release is expressly qualified by this cautionary statement. Readers are cautioned not to place undue reliance on forward-looking statements or information. The forward-looking information is made as of the date of this news release, and Levitee assumes no obligation to publicly update or revise such forward-looking information, except as required by applicable securities laws. The CSE (operated by CNSX Markets Inc.) has neither approved nor disapproved of the contents of this press release and accepts no responsibility for the adequacy or accuracy hereof.
For further information about Levitee Labs Inc., please contact:
Media Contact:
media@leviteelabs.com
Investor and Corporate Communications:
ir@leviteelabs.com
FAQ
What is Levitee Labs' participation in the Wonderland Miami Conference?
Who are the notable speakers at the Wonderland Miami Conference?
What is the significance of the Wonderland Miami Conference for Levitee Labs?
When is the Wonderland Miami Conference taking place?